Author:
Zhang Li-Jun,Xing Bin,Wu Jiang,Xu Bai,Fang Xiao-Ling
Subject
Pharmacology (medical),Biochemistry (medical),Pulmonary and Respiratory Medicine
Reference21 articles.
1. Molecular, cellular and clinical aspects of the pharmacology of (20S) camptothecin and its derivatives;Rivory;Pharmac Ther,1995
2. Distribution of camptothecin after delivery as a liposome aerosol or following intramuscular injection in mice;Koshkina;Cancer Chemother Pharmacol,1999
3. Preclinical evaluation of the anticancer activity and toxicity of 9-nitro-20(S)-camptothecin (Rubitecan);Giovanella;Int J Oncol,2002
4. 9-Nitrocamptothecin is an effective drug for the treatment of human lung tumors: comparison of in vitro and in vivo studies;Han;Anticancer Res,2001
5. A phase II trial with RFS2000 (rubitecan) in patients with advanced non-small cell lung cancer;Baka;Eur J Cancer,2005
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献